<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments

Neuro Therapies

Magstim: Opportunities in Transcranial Magnetic Stimulation: An Interview with Lothar Krinke

Magstim CEO Lothar Krinke, PhD discusses Magstim and opportunities in transcranial magnetic stimulation ...

Neuro Therapies

Medtronic DTM SCS: Using Basic Science to Orchestrate Pain Relief

Charlie Covert, VP/GM of Medtronic’s Pain Therapies business, discusses 12-month follow up data from the...

Neuro Therapies

PNS 2020: What’s New in Peripheral Nerve Stimulation?

In the market for Peripheral Nerve Stimulation (PNS), companies are developing new wireless or minimally...

Neuro Therapies

COVID-19 Resurgence: The Effect on Deferred Procedures

MedTech Strategist reported that In May of this year, the Deloitte Center for Health Solutions conducted...

Neuro Therapies

COVID Clobbers Spinal Cord Stimulation Market in Q220

COVID-19 hit the SCS market hard in Q220 as shutdowns and widespread procedure cancellations led to a dr...

Neuro Therapies

Elevating Stroke Care: An Interview with Imperative Care's Fred Khosravi

With plans to become a stroke strategic, Imperative Care Chairman and CEO Fred Khosravi discusses elevat...

Neuro Therapies

Cerenovus: Becoming a Key Player in Stroke: An Interview with Mark Dickinson

Mark Dickinson, Worldwide President of Cerenovus, discusses the Company’s focus on patients, innovation ...

Neuro Therapies

Growth Strategies Amid COVID-19: An Interview with Abbott's Keith Boettiger

Keith Boettiger, Vice President, Neuromodulation, Abbott discusses COVID-19 and the Company’s strategies...

Neuro Therapies

Stroke Care During an Evolving Pandemic: An Interview with J Mocco, MD

J Mocco, MD, MS discusses how an evolving pandemic is affecting stroke care in an interview with SmartTR...

Neuro Therapies

COVID-19 Slows SCS Market Momentum: Q120 Market Recap

The SCS market saw double-digit declines in Q120 as elective procedures fell off a cliff toward the end ...

1
...
7 8 9
...
14